Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20150291653 | PROCESS FOR PREPARING BILE ACID DERIVATIVES - The present invention relates to processes for preparing compounds of formula I: or a pharmaceutically acceptable salt or solvate thereof. | 10-15-2015 |
20140100209 | TGR5 Modulators and Methods of Use Thereof - The invention relates to compounds of Formula A: | 04-10-2014 |
20140094443 | TGR5 Modulators and Methods of Use Thereof - The invention relates to compounds of Formula A: | 04-03-2014 |
20140057886 | Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions - The present invention relates to compounds of formula (I): | 02-27-2014 |
20140024631 | Steroids as Agonists for FXR - The invention relates to compounds of formula (I): | 01-23-2014 |
20120283234 | Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions - The present invention relates to compounds of formula (I): | 11-08-2012 |
20120115832 | TGR5 Modulators and Methods of Use Thereof - The invention relates to compounds of Formula A: | 05-10-2012 |
20110172198 | TGR5 Modulators And Methods Of Use Thereof - The invention relates to compounds of Formula A: (A) or a salt, solvate, or hydrate thereof. The compounds of formula A are TGR5 modulators useful for the treatment of disease. | 07-14-2011 |
20100152151 | TGR5 MODULATORS AND METHODS OF USE THEROF - The invention relates to compounds of Formula A: | 06-17-2010 |
20100063018 | BILE ACID DERIVATIVES AS FXR LIGANDS FOR THE PREVENTION OR TREATMENT OF FXR-MEDIATED DISEASES OR CONDITIONS - The present invention relates to compounds of formula (I) | 03-11-2010 |
20100022498 | STEROIDS AS AGONISTS FOR FXR - The invention relates to compounds of formula (I): | 01-28-2010 |